IE
TWST icon

Israel Englander’s Twist Bioscience TWST Stock Holding History

Israel Englander’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.88M Buy
+28,000
New +$1.82M ﹤0.01% 3518
2021
Q4 		– Sell
-5,000
Closed -$535K – 7395
2021
Q3 		$535K Buy
+5,000
New +$573K ﹤0.01% 5283

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Israel Englander's TWST Position: Q2 2026 in Review

Israel Englander reduced its Twist Bioscience (TWST) stake by 0.99% in Q2 2026, selling an estimated $225K and leaving 347,148 shares worth $35.7M. The position accounts for 0.01% of the portfolio, ranked #1136.

Israel Englander first reported a position in TWST in Q2 2019 and has held it in 29 quarters since. The position peaked at $77.3M in Q3 2023. 334 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Israel Englander held 347,148 shares of Twist Bioscience worth $35.7M as of Q2 2026.
  • Israel Englander sold 3,456 Twist Bioscience shares in Q2 2026, an estimated $225K.
  • Twist Bioscience made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1136 holding.
  • Israel Englander first reported a position in Twist Bioscience in Q2 2019 and has held it in 29 quarters since.
  • Israel Englander's Twist Bioscience position peaked at $77.3M in Q3 2023.
  • 334 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.